Volibo 0.2 mg
Volibo 0.2 mg
Volibo 0.2 mg is an anti-glycaemic drug-containing Voglibose as the active ingredient. Voglibose belongs to a class of drugs known as an alpha-glucosidase inhibitor, which effectively controls high blood sugar levels in your body. Your doctor may recommend it if you have Type 2 diabetes. You may receive this treatment when other similar medicines or restricted diet regime is unable to control high blood sugar level. The medicine delays the absorption as well as digestion of dietary polysaccharides by reversibly inhibiting enzymes like maltose, sucrose, isomaltase, etc. This cause a reduction in postprandial hyperglycaemia.
In clinical trials, Volibo was proven extremely effective when using in combination with other anti-diabetic medicines. The drug found to reduce the blood sugar levels significantly. The medicine is effective for people whose blood sugar is not managed by other anti-diabetic medication. A doctor will be able to advise you whether the medicine is suitable for you or not. Usually, the anti-diabetic agent is safe and well tolerable for people with type 2 diabetes.
Dosage of Voglibose should be individualized based on effectiveness and tolerance. It is usually recommended three times a day for adequate blood sugar control. The total dose should not exceed the limit of 0.6 mg. The dose taken before meals has been effective, and most health care experts have recommended it. Generally, Volibose 0.2 mg once daily is the recommended dose. The tablet can be taken before or after a meal or snack. Swallow the tablet without chewing, breaking, or crushing it. If you miss a dose; please consume it immediately once you remember. However, if you remember the next day, skip the missed dose and continue with your regular dosing schedule. Do not attempt to take two doses on the same day to make up for the missed one.
Always take medicine according to the doctor’s instructions. Depending on your response to the treatment, the doctor alters your dose. Your dose may increase or decrease depending on your condition. You should check with your doctor if you are not sure. Volibo 0.2 mg should not be given to patients with known hypersensitivity to Voglibose or other inactive constituents. People are suffering from inflammatory bowel syndrome, diabetic ketoacidosis, colonic ulceration, partial intestinal obstruction, and chronic disorders associated with digestion and absorption. The anti-diabetic drug should be given with caution when used along with other anti-diabetic agents such as glucuronide, sulfonyl amide, sulfonylurea, and insulin preparations for improving insulin resistance.
Side Effects of Volibo
Research studies have shown that Volibo helps to control blood sugar in patients with type 2 Diabetes Mellitus. But the drug to causes side effects. Most common side effects of Volibo 0.2 mg are given below:
- Gastrointestinal tract - flatulence, bloating, abdominal pain, diarrhoea, abdominal fullness, and nausea
- Liver problems - hepatitis with severe cholestasis
- Central nervous system disorders - vomiting, nausea, and dizziness.
Let your physician know about your medical history as well as current physical status along with the medicines you have been using. This helps your physician in determining the best treatment for you.